scispace - formally typeset
C

Chad D. Geringer

Researcher at Eli Lilly and Company

Publications -  5
Citations -  886

Chad D. Geringer is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Gene chip analysis & Promoter. The author has an hindex of 4, co-authored 5 publications receiving 856 citations.

Papers
More filters
Journal ArticleDOI

Analysis of regulator of G‐protein signaling‐2 (RGS‐2) expression and function in osteoblastic cells

TL;DR: The data suggest that PTH treatment results in a direct transcriptional stimulation of RGS‐2 that in turn may play a role in modulating the duration/intensity of PTH receptor signaling.
Journal ArticleDOI

Aldosterone stimulates angiotensin-converting enzyme expression and activity in rat neonatal cardiac myocytes.

TL;DR: ACE gene expression may be a target for mineralocorticoid receptors in the myocardium, supporting the notion that at least some of the known adverse effects of aldosterone on the myCardium are mediated by increased angiotensin II.
Journal ArticleDOI

Assessing the Variability in GeneChip® Data

TL;DR: This paper introduces statistical methods to assess the variability of Affymetrix GeneChip® data due to randomness and finds that the biological and chip variation are roughly comparable.